Bank of America Corp DE grew its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 19.0% in the 4th quarter, Holdings Channel reports. The firm owned 79,310 shares of the company’s stock after acquiring an additional 12,667 shares during the quarter. Bank of America Corp DE’s holdings in Nu Skin Enterprises were worth $4,863,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of NUS. Bank of New York Mellon Corp lifted its stake in Nu Skin Enterprises by 0.4% during the third quarter. Bank of New York Mellon Corp now owns 820,216 shares of the company’s stock worth $67,601,000 after purchasing an additional 3,213 shares during the last quarter. Martingale Asset Management L P lifted its stake in Nu Skin Enterprises by 10.8% during the third quarter. Martingale Asset Management L P now owns 158,105 shares of the company’s stock worth $13,032,000 after purchasing an additional 15,450 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in Nu Skin Enterprises during the third quarter worth about $224,000. Paloma Partners Management Co bought a new stake in Nu Skin Enterprises during the third quarter worth about $356,000. Finally, BlueMountain Capital Management LLC bought a new stake in Nu Skin Enterprises during the third quarter worth about $514,000. 76.15% of the stock is owned by hedge funds and other institutional investors.

NYSE NUS opened at $48.54 on Wednesday. Nu Skin Enterprises, Inc. has a 1-year low of $44.36 and a 1-year high of $88.68. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.82 and a quick ratio of 1.15. The stock has a market capitalization of $2.76 billion, a PE ratio of 13.79, a P/E/G ratio of 1.20 and a beta of 0.65.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, February 13th. The company reported $1.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.05. Nu Skin Enterprises had a return on equity of 25.98% and a net margin of 4.55%. The company had revenue of $683.29 million during the quarter, compared to analyst estimates of $676.76 million. During the same quarter in the previous year, the company posted $1.20 EPS. Nu Skin Enterprises’s revenue for the quarter was up 2.6% on a year-over-year basis. Equities research analysts forecast that Nu Skin Enterprises, Inc. will post 3.83 earnings per share for the current year.

Several brokerages have issued reports on NUS. Stifel Nicolaus lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating and dropped their price target for the stock from $63.00 to $43.00 in a research note on Monday, March 25th. Zacks Investment Research lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Tuesday, January 8th. ValuEngine lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Friday, February 8th. TheStreet lowered Nu Skin Enterprises from a “b” rating to a “c+” rating in a research note on Thursday, February 14th. Finally, Pivotal Research reissued a “buy” rating and issued a $85.00 target price on shares of Nu Skin Enterprises in a research note on Wednesday, February 13th. Three analysts have rated the stock with a sell rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $76.86.

ILLEGAL ACTIVITY NOTICE: “Nu Skin Enterprises, Inc. (NUS) Position Boosted by Bank of America Corp DE” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.watchlistnews.com/nu-skin-enterprises-inc-nus-position-boosted-by-bank-of-america-corp-de/2983514.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Featured Story: Analyzing a company’s cash flow statement

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.